Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency

Aims/Introduction: Chronic kidney disease (CKD)-mineral and bone disorders (CKD-MBD) are an adverse outcome derived from decreases in kidney function, where abnormality of serum concentrations of calcium (Ca), phosphorus, parathyroid hormone (PTH), and vitamin D can be seen simultaneously. To identi...

Full description

Bibliographic Details
Main Authors: Makoto Daimon, Tomoyuki Fujita, Masaya Murabayashi, Satoru Mizushiri, Hiroshi Murakami, Yuki Nishiya, Jutaro Tanabe, Yuki Matsuhashi, Miyuki Yanagimachi, Itoyo Tokuda, Kaori Sawada, Kazushige Ihara
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.00221/full
_version_ 1828969836753977344
author Makoto Daimon
Tomoyuki Fujita
Masaya Murabayashi
Satoru Mizushiri
Hiroshi Murakami
Yuki Nishiya
Jutaro Tanabe
Yuki Matsuhashi
Miyuki Yanagimachi
Itoyo Tokuda
Kaori Sawada
Kazushige Ihara
author_facet Makoto Daimon
Tomoyuki Fujita
Masaya Murabayashi
Satoru Mizushiri
Hiroshi Murakami
Yuki Nishiya
Jutaro Tanabe
Yuki Matsuhashi
Miyuki Yanagimachi
Itoyo Tokuda
Kaori Sawada
Kazushige Ihara
author_sort Makoto Daimon
collection DOAJ
description Aims/Introduction: Chronic kidney disease (CKD)-mineral and bone disorders (CKD-MBD) are an adverse outcome derived from decreases in kidney function, where abnormality of serum concentrations of calcium (Ca), phosphorus, parathyroid hormone (PTH), and vitamin D can be seen simultaneously. To identify individuals at risk for CKD-MBD or secondary hyperparathyroidism, the relationships between estimated glomerular filtration rate (eGFR) and serum PTH concentration were evaluated, allowing for confounding factors, in particular vitamin D status, in a general Japanese population.Materials and Methods: Nine-hundred-and-thirty participants in the population-based Iwaki study conducted in 2016 who were not on drugs affecting mineral metabolism nor hemodialysis, were included in the study (326 men and 604 women; age: 55.4 ± 15.9 years).Results: Regression analysis showed a significant correlation between eGFR and serum intact PTH concentration, after adjustment for possible confounding factors (β = −0.122, p < 0.001). The smoothed spline curve applied for the correlation analysis revealed a biphasic correlation, with a division at an eGFR of ~60 mL/min/1.73 m2, below which the correlation coefficient was higher (β = −0.405, p < 0.001). Stratification on the basis of vitamin D status showed that the correlation was present only in participants with vitamin D deficiency (25-dihydroxyvitamin D3: <15 pg/mL) (β = −0.154, p < 0.001).Conclusions: These results indicate that a reduction in eGFR is a significant risk factor for an increase in serum PTH concentration when it is <60 mL/min/1.73 m2 and vitamin D is deficient, in the general Japanese population.
first_indexed 2024-12-14T12:38:25Z
format Article
id doaj.art-02568cf8965b47e48474fb7216ca7f68
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-14T12:38:25Z
publishDate 2020-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-02568cf8965b47e48474fb7216ca7f682022-12-21T23:00:58ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2020-06-01710.3389/fmed.2020.00221536251Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D DeficiencyMakoto Daimon0Tomoyuki Fujita1Masaya Murabayashi2Satoru Mizushiri3Hiroshi Murakami4Yuki Nishiya5Jutaro Tanabe6Yuki Matsuhashi7Miyuki Yanagimachi8Itoyo Tokuda9Kaori Sawada10Kazushige Ihara11Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki, JapanDepartment of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki, JapanDepartment of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki, JapanDepartment of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki, JapanDepartment of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki, JapanDepartment of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki, JapanDepartment of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki, JapanDepartment of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki, JapanDepartment of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki, JapanDepartment of Oral Healthcare Science, Hirosaki University Graduate School of Medicine, Hirosaki, JapanDepartment of Social Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, JapanDepartment of Social Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, JapanAims/Introduction: Chronic kidney disease (CKD)-mineral and bone disorders (CKD-MBD) are an adverse outcome derived from decreases in kidney function, where abnormality of serum concentrations of calcium (Ca), phosphorus, parathyroid hormone (PTH), and vitamin D can be seen simultaneously. To identify individuals at risk for CKD-MBD or secondary hyperparathyroidism, the relationships between estimated glomerular filtration rate (eGFR) and serum PTH concentration were evaluated, allowing for confounding factors, in particular vitamin D status, in a general Japanese population.Materials and Methods: Nine-hundred-and-thirty participants in the population-based Iwaki study conducted in 2016 who were not on drugs affecting mineral metabolism nor hemodialysis, were included in the study (326 men and 604 women; age: 55.4 ± 15.9 years).Results: Regression analysis showed a significant correlation between eGFR and serum intact PTH concentration, after adjustment for possible confounding factors (β = −0.122, p < 0.001). The smoothed spline curve applied for the correlation analysis revealed a biphasic correlation, with a division at an eGFR of ~60 mL/min/1.73 m2, below which the correlation coefficient was higher (β = −0.405, p < 0.001). Stratification on the basis of vitamin D status showed that the correlation was present only in participants with vitamin D deficiency (25-dihydroxyvitamin D3: <15 pg/mL) (β = −0.154, p < 0.001).Conclusions: These results indicate that a reduction in eGFR is a significant risk factor for an increase in serum PTH concentration when it is <60 mL/min/1.73 m2 and vitamin D is deficient, in the general Japanese population.https://www.frontiersin.org/article/10.3389/fmed.2020.00221/fullCKDPTHvitamin Dpopulation based studyenvironmental interaction
spellingShingle Makoto Daimon
Tomoyuki Fujita
Masaya Murabayashi
Satoru Mizushiri
Hiroshi Murakami
Yuki Nishiya
Jutaro Tanabe
Yuki Matsuhashi
Miyuki Yanagimachi
Itoyo Tokuda
Kaori Sawada
Kazushige Ihara
Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency
Frontiers in Medicine
CKD
PTH
vitamin D
population based study
environmental interaction
title Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency
title_full Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency
title_fullStr Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency
title_full_unstemmed Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency
title_short Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency
title_sort exacerbation of hyperparathyroidism secondary to a reduction in kidney function in individuals with vitamin d deficiency
topic CKD
PTH
vitamin D
population based study
environmental interaction
url https://www.frontiersin.org/article/10.3389/fmed.2020.00221/full
work_keys_str_mv AT makotodaimon exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency
AT tomoyukifujita exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency
AT masayamurabayashi exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency
AT satorumizushiri exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency
AT hiroshimurakami exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency
AT yukinishiya exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency
AT jutarotanabe exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency
AT yukimatsuhashi exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency
AT miyukiyanagimachi exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency
AT itoyotokuda exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency
AT kaorisawada exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency
AT kazushigeihara exacerbationofhyperparathyroidismsecondarytoareductioninkidneyfunctioninindividualswithvitaminddeficiency